Investigation of Novel Triterpenoids as New Potent AMPK Activators for the Treatment of Insulin Resistant States [ 2009 - 2012 ]

Also known as: New Therapeutics Derived from Traditional Medicines for the Treatment of Type 2 Diabetes

Research Grant

[Cite as]

Researchers: Prof Jiming Ye (Principal investigator) ,  Dr Bronwyn Hegarty Prof Yang Ye

Brief description Type 2 Diabetes has major economic and health implications. Current medications are inadequate or have serious adverse effects. Triterpenoids have been used in traditional medicines for various diseases. This project builds on our recent discovery of novel triterpenoids with antidiabetic properties to investigate their efficacy and mechanisms of action. The results will provide valuable information about this class of molecules as potential new therapeutics for Type 2 diabetes.

Funding Amount $AUD 574,075.74

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]